International Clinical Trial: A Multicenter, Open-Label, Prospective, Parallel-Controlled Study on the Improvement of Hypoalbuminemia in Peritoneal Dialysis and Hemodialysis Patients by a Protein Component Formula Food for Special Medical Purposes (ShuChang)

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131573) titled 'A Multicenter, Open-Label, Prospective, Parallel-Controlled Study on the Improvement of Hypoalbuminemia in Peritoneal Dialysis and Hemodialysis Patients by a Protein Component Formula Food for Special Medical Purposes (ShuChang)' on Sept. 4.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Zhejiang Provincial Hospital of TCM

Condition: Peritoneal Dialysis (PD) Hemodialysis (HD) Hypoalbuminemia

Intervention: Peritoneal Dialysis Control Group:None Peritoneal Dialysis Treatment Group:Two sachets of Shuchang daily, one in the morning and one in the evening, taken between ...